Hotchkiss Brain Institute, University of Calgary
13
2
2
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 75/100
23.1%
3 terminated/withdrawn out of 13 trials
57.1%
-29.4% vs industry average
23%
3 trials in Phase 3/4
0%
0 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (13)
Transcranial Magnetic Stimulation for Depression in Multiple Sclerosis
Role: collaborator
Improving Sleep to Prevent Depression & Anxiety in Adolescents at High Risk
Role: collaborator
Pharmacogenetics of Antidepressant-Induced Disinhibition
Role: collaborator
Internet Delivered Psychotherapy for Older Adults
Role: collaborator
Early Treatment of Atrial Fibrillation for Stroke Prevention Trial in Acute STROKE
Role: collaborator
Trial of MR-guided Focused Ultrasound (MRgFUS) Bilateral Capsulotomy for the Treatment of Refractory Obsessive-compulsive Disorder (OCD)
Role: collaborator
Treating Persistent Post-concussion Symptoms With Exercise
Role: collaborator
Minocycline in MS: Confirmation of Benefit
Role: collaborator
Mean Arterial Blood Pressure Treatment for Acute Spinal Cord Injury
Role: collaborator
rTMS Treatment of Persistent Headache and Post Concussion Symptoms Attributed to Mild Traumatic Injury to the Head
Role: collaborator
A Registry-Based Clinical Trial of Pimozide in Patients With Neuromuscular Junction Transmission Dysfunction Due to ALS
Role: collaborator
Endovascular Treatment for Small Core and Proximal Occlusion Ischemic Stroke
Role: collaborator
Minocycline and Perfusion Pressure Augmentation in Acute Spinal Cord Injury
Role: collaborator
All 13 trials loaded